POU6F2 and non-small cell lung carcinoma: Using RT-ddPCR, we could confirm POU6F2-AS2 as a tumor-associated transcript in plasma samples from 45 stage IV NSCLC patients and 39 stage I–III NSCLC patients (Figure 3B).